Riskpilot← Back to searchSign inGet full accessMeda Aktiebolag
ABActiveOrg 5564272812Pipers Väg 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19910 employees
Revenue 2024
SEK 3,7B
+29% vs 2023
EBITDA margin
45.9%
+6% vs 2023
Equity ratio
17.3%
Financial strength
Net profit 2024
SEK -237M
-6025% vs 2023
| Revenue | SEK 3,7B | +29% |
| EBITDA | SEK 1,7B | +6% |
| Net profit | SEK -237M | -6025% |
| Total assets | SEK 20,1B | -9% |
| Equity | SEK 3,5B | -17% |
| Employees | 0 | — |
Legal name
Meda Aktiebolag
Org number
5564272812
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6 juni 1991
Share capital
SEK 365 000 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att idka handel med och tillverkning av produkter för hälsovård, sjukvård och friskvård samt därmed förenlig verksamhet. Bolaget skall även äga och förvalta fast och lös egendom, däribland aktier och andelar i andra företag.
Address
Pipers Väg 2
Phone
+4686301900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 451 000 | 6 490 000 | 2 862 000 | 2 834 000 | 3 668 000 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 390 000 | 1 744 000 | 1 280 000 | 1 591 000 | 1 683 000 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 1 390 000 | 1 744 000 | 1 280 000 | 1 591 000 | 1 683 000 |
| Net financials | −2 479 000 | 18 000 | 116 000 | −508 000 | −321 000 |
| Profit before tax | −1 347 000 | 257 000 | 260 000 | 289 000 | −260 000 |
| Tax | 192 000 | −15 000 | −5 000 | −285 000 | 23 000 |
| Net profit | −1 155 000 | 242 000 | 255 000 | 4 000 | −237 000 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 910 000 | 22 872 000 | 26 370 000 | 22 111 000 | 20 133 000 |
| Equity | 3 721 000 | 3 960 000 | 4 215 000 | 4 219 000 | 3 482 000 |
| Long-term debt | 15 006 000 | 17 216 000 | 19 135 000 | 15 484 000 | 11 171 000 |
| Short-term debt | 8 057 000 | 1 583 000 | 2 899 000 | 2 193 000 | 5 257 000 |
| Total debt | 23 063 000 | 18 799 000 | 22 034 000 | 17 677 000 | 16 428 000 |
EBITDA margin
45.9%
This company
15.8%
Market median
+191% vs market
20202024
Equity ratio
17.3%
This company
38.2%
Market median
-55% vs market
20202024
Return on equity
-6.8%
This company
18.4%
Market median
-137% vs market
20202024
Net profit margin
-6.5%
This company
8.1%
Market median
-180% vs market
20202024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20202024
Debt / equity
4.78×
This company
0.62×
Market median
-671% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LH Chief Executive Officer | Chief Executive Officer | 2022 |
AP Chief Auditor | Chief Auditor | 2021 |
| Former (3) | ||
JJ Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
VS Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
LD Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UTAH ACQUISITION SUB INC.Bgp Products AB
Meda Aktiebolag (this company)Mylan Finland OyBgp Pharma UlcMeda ASMeda OyMeda Pharma Hungary Kft.Viatris OyMeda Pharma Hungary KftMeda Health Sales Ireland LtdViatris Pharmaceuticals LtdMeda Pharma s De Rl De CvMeda Pharma S De Rl De CvMeda Pharmaceutcals Sp.Z.O.O.Meda Health Sales Ireland Ltd.Mylan Uk Healthcare LimitedMeda Pharmaceuticals SaViatris ApsMylan Pharma GmbhViatris ASViatris Uk Healthcare LimitedMeda A/SMeda Pharma Itac Sanayi Ve Ticaret Limited SirkeMylan Healthcare Norge ASMeda Pharmaceutcals Sp ZooBGP PHARMA ULCMEDA HEALTH SALES IRELAND LTD.VIATRIS ASMEDA PHARMA ITAC SANAYI VE TICARET LIMITED SIRKEVIATRIS UK HEALTHCARE LIMITEDVIATRIS APSMed Pharma S.A.R.lMeda Pharma Servicios S. De Rl De C.vMylan Philipines IncMeda Pharmaceuticals Hong Kong Ltd.Laboratàrios Delta, Lda.Meda Pharmaceuticals Middle East & Africa Fz LlcMeda Pharma S.A./N.V.Meda Pharma SiaMedicine Meda Pharmaceutical Information ConsultMeda Pharma Spol S.R.O.Meda Pharma Ilac San.I Ve Tic. LtdMeda Pharma S.R.O.Laboratorios Delta SaMeda Pharmacentials Ltd.Meda Pharma LlcMeda Pharma South Africa (Pty) LtdMeda Pharma Produtos Farmac?Uticals S.A.Meda Pharmaceuticals Switzerland GmbhMeda Pharma S.L.Meda Pharma GmbhMeda Pharma S.A.R.lMeda Holding SasMeda Healthcare Sdn. Bhd.Mylan Österreich GmbhMED PHARMA S.A.R.LMEDA HEALTHCARE SDN. BHD.MEDA PHARMA S.L.MEDA PHARMACEUTICALS HONG KONG LTD.MEDA PHARMA S.A./N.V.MEDA PHARMA SOUTH AFRICA (PTY) LTDLABORATORIOS DELTA SAMEDA PHARMA LLCMYLAN PHILIPINES INCMYLAN ÖSTERREICH GMBHMEDA PHARMA SERVICIOS S. DE RL DE C.VMEDA PHARMACEUTICALS SWITZERLAND GMBHVIATRIS OYMEDA PHARMACEUTCALS SP.Z.O.O.MYLAN PHARMA GMBHBoard members of Meda Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Henrik Andreas Rejnus | Chief Executive Officer | 0 companies |
| Arne Pontus Pålsson | Chief Auditor | 0 companies |
| Jose Javier Cotarelo | Chief Executive Officer | 0 companies |
| Vidar Sie | Chief Executive Officer | 0 companies |
| Lars Daniel Wassberg | Chief Auditor | 0 companies |
| Bernard Christiaan Spoelstra | Board of Directors | 0 companies |
| Caroline Rebecca Louise Dixon | Board of Directors | 0 companies |
| Jenny Friberg | Board of Directors | 0 companies |
| Jan-Christer Stefan Engryd | Board of Directors | 0 companies |
| Alan Roy Weiner | Board of Directors | 0 companies |